drugset / Trial / NCT01492894

Kidney Allograft Dysfunction Without Reversible Causes

NCT01492894

Phase 4 Withdrawn University of Minnesota
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to learn the best way to prolong kidney life in patients exposed to calcineurin inhibitors, who already have evidence of damage possibly caused by the calcineurin inhibitor on kidney biopsy.

Timeline

Start
2008-01
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide
Comparator Sirolimus Small molecule
Comparator Tacrolimus Small molecule